secwatch.observer — SEC 8-K summary
======================================

Issuer:     IRADIMED CORP (IRMD)
CIK:        0001325618
Form:       8-K
Filed at:   2022-10-06T23:59:59+00:00
Accession:  0000898432-22-000615
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

iRadimed appoints Hilda Scharen-Guivel to Board of Directors, effective Oct 4, 2022
--------------------------------------------------------------------------------

- Board expanded to five directors; three are independent, including Scharen-Guivel.
- Scharen-Guivel recently retired from FDA as Program Director of CDRH; 25+ years in federal agencies.
- She will receive standard non-employee director compensation per 2022 proxy statement.
- Scharen-Guivel has no material relationship with iRadimed; no transactions under Item 404(a).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1325618/000089843222000615/0000898432-22-000615-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1325618/000089843222000615/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0000898432-22-000615

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer